85 related articles for article (PubMed ID: 19088827)
1. [Expression of MMP-2 and its clinical significance in cervical squamous carcinoma].
Kong LL; Cui W; Wang XC; Wang X; Yang QY; Song XY; Jiang XG; Yan CY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):583-5. PubMed ID: 19088827
[TBL] [Abstract][Full Text] [Related]
2. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
Wu SH; Zhang J; Li Y; Li JM
Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
[TBL] [Abstract][Full Text] [Related]
3. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.
Sheu BC; Lien HC; Ho HN; Lin HH; Chow SN; Huang SC; Hsu SM
Cancer Res; 2003 Oct; 63(19):6537-42. PubMed ID: 14559848
[TBL] [Abstract][Full Text] [Related]
4. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
5. Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis.
Murakami A; Fukushima C; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Ismail E; Al-Mulla F; Sugino N
Cancer Lett; 2011 Dec; 311(1):77-84. PubMed ID: 21824723
[TBL] [Abstract][Full Text] [Related]
6. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of clinical significances of p-extracellular regulated kinase 1/2 and matrix metalloproteinase-9 in cervical squamous cell carcinoma].
An FX; Wang X; Liu W; Gao YL; Ma JL; Xu XX; Chen SM; Yang M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):590-4. PubMed ID: 23286404
[TBL] [Abstract][Full Text] [Related]
8. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
9. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
Luo CF; Zhu RQ; Wang H; Lu YL
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
[TBL] [Abstract][Full Text] [Related]
10. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
15. Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence.
Wang PH; Ko JL
Int J Gynecol Cancer; 2006; 16(5):1873-9. PubMed ID: 17009985
[TBL] [Abstract][Full Text] [Related]
16. A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.
Yang SF; Wang PH; Lin LY; Ko JL; Chen GD; Yang JS; Lee HS; Hsieh YS
Reprod Sci; 2007 Oct; 14(7):710-8. PubMed ID: 18000233
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer.
Moser PL; Kieback DG; Hefler L; Tempfer C; Neunteufel W; Gitsch G
Anticancer Res; 1999; 19(5C):4391-3. PubMed ID: 10650781
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.
Xie M; Sun Y; Li Y
Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]